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We investigate the potential of multiple quantum filtered (MQF) 23Na NMR to probe 
intracellular [Na]i in the Langendorff perfused mouse heart. In the presence of 
Tm(DOTP) shift reagent the triple quantum filtered (TQF) signal originated largely from 
the intracellular sodium pool with a 32 ± 6 % contribution of the total TQF signal 
arising from extracellular sodium, whilst the rank 2 double-quantum filtered signal 
(DQF), acquired with a 54.7° flip-angle pulse, originated exclusively from the 
extracellular sodium pool. Given the different cellular origins of the 23Na MQF signals 
we propose that the TQF/DQF ratio can be used as a semi-quantitative measure of 
[Na]i in the mouse heart. We demonstrate a good correlation of this ratio with [Na]i 
measured with shift reagent at baseline and under conditions of elevated [Na]i. We 
compare the measurements of [Na]i using both shift reagent and TQF/DQF ratio in a 
cohort wild type mouse hearts and in a transgenic PLM 3SA mouse harbouring a non-
phosphorylatable phospholemman, showing a modest but measurable elevation of 
baseline [Na]I in this model. MQF filtered 
23Na NMR is a potentially useful tool for 
studying normal and pathophysiological changes in [Na]i, particularly in transgenic 
mouse models with altered Na regulation. 
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Intracellular Na concentration [Na]i is a key modulator of cardiac cell function [1]. At 
steady-state [Na]i has been measured between 4-16mM depending on species and 
preparation [2]. The Na electrochemical gradient across the cell membrane provides 
the energy for the action potential upstroke, as well as the active transport of many 
other ions, amino acids and substrates into the cell [2, 3]. [Na]i is also critical for the 
control of intracellular calcium [Ca]i via the sodium-calcium exchanger (NCX), thereby 
determining sarcoplasmic reticulum (SR) Ca content and cardiac contractility [4]. 
Maintenance of the Na+ gradient is therefore fundamentally important in normal 
physiology but is also critically important in cardiac hypertrophy and heart failure 
where the elevation of [Na]i contributes to contractile and electrical dysfunction [5-7].  
Historically, many techniques have been used to measure intracellular Na but 
few are physiologically relevant, either measuring Na at room temperature or in 
quiescent preparations [1]. 23Na Nuclear Magnetic Resonance (NMR) is able to 
distinguish intra versus extracellular Na pools, employing paramagnetic shift reagents 
such as Tm(DOTP) [8] to separate the two. However, these reagents are efficient 
chelators of Ca and Mg leading to modified ion homeostasis and reduced cardiac 
contractility [9]. As a result, shift reagents exhibit significant toxicity precluding their 
use in vivo. In contrast, multiple quantum filtered (MQF) 23Na nuclear magnetic 
resonance has shown great potential to probe intra and extracellular pools of Na in the 
absence of shift reagent and therefore under more physiological conditions [10, 11]. 
Much work has been carried out developing multiple quantum filtered 23Na NMR in 
the perfused rat heart [10, 12, 13], in vivo in skeletal muscle and the brain [14] and in 
tumours [15]. In the perfused rat heart, the 23Na TQF signal has contributions from the 
intra and extracellular Na pools [11, 16, 17] and has been shown to be proportional to 
intracellular [Na]i measured by atomic absorbtion spectroscopy [13]. Methods have 
been developed to suppress the extracellular contribution to the TQF signal [18]. On 
the other hand, the 23Na DQF signal was found previously to arise only from the 
extracellular Na pool in the rat heart suggesting that TQF and DQF 23Na NMR signal 
arise from different cellular compartments [19].  
While the isolated rat heart has historically been an important model for 
cardiovascular research, the ability to rapidly and efficiently manipulate the genome of 
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the mouse has recently made this the species of choice for many physiological and 
biochemical studies. The application of MQF 23Na NMR techniques to the isolated 
perfused mouse heart are much more challenging due to technical issues of the 
smaller heart size and, prior to this study, have not been described. The aim of the 
present study was therefore to revisit the utility of the multiple quantum filtered 
experiment and to establish and characterise the methods necessary to apply MQF 
23Na NMR measurements to isolated Langendorff-perfused mouse hearts in both wild-
type and a transgenic PLM 3SA genotype displaying altered [Na]i homeostasis. 
 
Methods 
Langendorff mouse heart perfusion: C57BL/6J male mice (~28g body weight) were 
purchased from Harlan (Harlan, UK). PLM 3SA mice were derived from a colony as 
previously described (ref). Mice were kept in individually ventilated cages with a 12h 
light-dark cycle, controlled humidity and temperature (20-22ºC), fed standard chow 
and water ad libitum. All experiments were approved by institutional ethical review 
committee and conform to the UK Home Office Guidance on the Operation of the 
Animals Scientific Procedures Act 1986 (HMSO). 
Mice were administered terminal anaesthesia via intra-peritoneal 
pentobarbitone injection (~140 mg/kg body weight). Hearts were rapidly excised, 
cannulated and perfused in isovolumic Langendorff mode and perfused at 80 mmHg 
pressure maintained by a STH peristaltic pump controller feedback system (AD 
Instruments, Oxford, UK), at 37°C with Krebs-Henseleit (KH) buffer continuously gassed 
with 95% O2/5% CO2  (pH 7.4) containing (in mM): NaCl 116, KCl 4.7, MgSO4.7H2O 1.2, 
NaHCO3 25, KH2PO4 1.4, CaCl2 1.4, glucose 11 [20]. Cardiac function was assessed using 
a fluid-filled cling-film balloon inserted into left ventricle (LV), and connected via a rigid 
polyethylene line to an MR-compatible pressure transducer (DTX Plus TNF-R, Becton-
Dickinson) and a PowerLab system (AD Instruments, Australia). The volume in the 
intraventricular balloon was adjusted using a 1.0 ml syringe to achieve an initial LV 
diastolic pressure of ~9mmHg. Left ventricular developed pressure (LVDP) was 
calculated from the difference between systolic (SP) and diastolic pressures (DP). 
Functional parameters (systolic pressure, end-diastolic pressure, heart rate, LVDP, 
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coronary flow, perfusion pressure) were monitored using LabChart software v.7 (AD 
Instruments, Australia) throughout the experiment [21]. 
The low flow rates and the long perfusion lines in NMR systems can create 
problems with adequate temperature control. In addition, these long perfusion lines 
create significant ‘dead-spaces’ (where temperature, gas solubility and pH may 
change) and introduce long delays on switching solutions. These problems were solved 
in the current system by the use of two parallel continuously recirculating water-
jacketed perfusion lines (Figure 1a). Control, and test solutions were gassed at 37oC 
before being pumped (Gilson Minipuls 3) through two parallel lines within a water-
jacketed (37oC) umbilical line (approx 3 metres in length). These two lines then enter a 
novel three-way pneumatically operated valve positioned directly above the cannula 
(Figure 1a). Control solution was passed via the pneumatic valve to the heart while the 
test solution was recirculated back up the umbilicus to the external reservoir. When 
the valve is activated, the control solution is recirculated and the test solution passes 
to the heart with effectively no distal stagnant dead-space and a switching time of 
<2sec, at the level of the heart. In order to protect the magnet, coils etc from 
accidental leakage, the perfusion system includes a ‘flood plain’ between the perfusion 
lines, valve etc and the cannula (Fig. 1a). This flood plain includes a moisture sensor 
connected to a remote alarm. The umbilical line, transducers, valve and all fittings 
were manufactured exclusively of non-magnetic parts and was fed via the top of the 
magnet and lowered into the active region of the bore/microimaging coil. At the end 
of each experiment, the perfusion system was removed from the magnet and hearts 
were immediately snap frozen using Wollenberger tongs, pre-cooled in liquid nitrogen, 
and wet and dry weights were recorded.  
 
NMR Spectroscopy: All experiments were carried out on a Bruker Avance III 400 MHz 
wide-bore spectrometer (Bruker, Karlsruhe, Germany) equipped with triple-axis 
gradients, a microimaging probe and exchangeable RF coil inserts (10mm 23Na coil or 
1H/31P dual tune coil) that enable rapid switching between different nuclei. NMR tubes 
(O.D. 10mm) (Wilmad, UK) were shortened in length to just greater than the NMR 
active coil region in order to minimize the perfusate dead volume beneath the heart. 
The bore of the NMR was maintained (~313K) by continuous delivery of warm water, 
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from a thermostatically controlled water bath, through the imaging gradients of the 
MR. Temperature calibration was performed in situ using a capillary containing 
ethylene glycol at the position of the heart. 
To analyse the relationship between [Na]i elevation and TQF and DQF signal 
intensities, hearts were equilibrated for 20mins, followed by 20min treatment with: (i) 
standard KHB (n=6) (ii) 50M ouabain (n=6), (iii) K+- free buffer (n=3), (iv) K+-free/Ca2+-
free (n=3) or (v) K+-free/Ca2+-free/Mg2+-free (n=3) buffer. Interleaved TQF and DQF 
NMR acquisitions were recorded throughout the stability period and during the 
intracellular sodium elevation protocols. At the end of each intervention, perfusate 
was switched to KHB containing 5mM Tm(DOTP)5- to shift the extracellular [Na]e signal 
and quantify [Na]i. An intracellular volume of 2.5 ml/g dry weight of tissue was 
assumed for calculation of [Na]i [22]. 
 In order to confirm that cardiac energetics were normal and not compromised 
prior to any elevation in [Na]i, fully relaxed 
31P experiments were also performed with 
the same perfusion system and phosphate free buffer, acquired with a 60° flip angle, 
256 scans, a repetition time of 3.8s and a total experiment duration of 16mins. 
 
Multiple Quantum Filtering 23Na MRS: The multiple quantum filtered pulse sequence 
consists of [10]: 90°(1)  m/2  180º(2)  m/2 º(2)   º(3) – FID(rec). DQF 
experiments were acquired with a four-step phase cycle: 1= 2 = 90, 180, 270, 0; 
3 = 0; rec = 0, 180, 0, 180. The flip angle  was set either to the magic angle, 
54.7 (rank 2 T2,±2 only) or to 90 (both rank 2 T2,±2 and rank 3 T3,±2). TQF experiments 
were acquired with a six-step phase cycle: 1 = 30, 90, 150, 210, 270, 330; 2 = 
120, 180, 240, 300, 0, 60; 3 = 0; rec = 0, 180, 0, 180, 0, 180 with the flip 
angle  = 90 (rank 3 T3,±3 only). The mixing time ( = 3.6ms) was calibrated for the 
maximum TQF signal in the mouse heart and set to be the same for the DQF 
experiments. All MQF experiments were acquired with 192 scans, 2048 data points, 
sweep width of 50ppm, an acquisition time of 200ms, pre-scan delay of 200ms and a 
total acquisition time of 1.24 mins. An exponential line broadening factor of 10Hz was 
applied prior to Fourier transformation and subsequent baseline correction. 
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Shift reagent 23Na MRS : All hearts were perfused at the end of the protocol with 
modified KHB containing 5mM Tm(DOTP)5- (thulium (III) 1,4,7,10-
tetraazacyclododecane-N,N’N’’,N’’’tetra(methyl-enephosphonate)) (Macrocyclics, 
Dallas, USA). 23Na acquisitions were recorded in real-time during the perfusion with 
the shift reagent until the extracellular [Na]e peak was completely shifted (5-10mins) 
(Figure 2b). Following infusion of shift reagent a single quantum spectrum was 
acquired with 128 scans, 2048 data points, sweep width of 50ppm, an acquisition time 
of 200ms, pre-scan delay of 200ms and a total acquisition time of 50s. An exponential 
line broadening factor of 10Hz was applied prior to Fourier transformation and 
subsequent baseline correction. The resulting [Na]i peak was referenced to a glass bulb 
containing 2.9µmol NaCl with 10mM Tm(DOTP)5- at the position of the heart. The Na 
present in the calibration bulb was assumed to be 100% NMR visible ie fo = 1.0.  The 
visibility of intracellular Na is more controversial but, in these studies, was assumed to 
be fi = 0.4 and this was assumed to remain constant throughout the experimental 
protocol. [23-25]. 
 
Statistical Analysis: Data were analysed and expressed as mean ± standard error of the 
mean (SEM), n = number of independent experiments.  Where appropriate, statistical 
analysis was performed using Students t-test and relationship between variables 
analysed using Pearson correlation. P<0.05 was considered statistically significant. 
 
Results 
Table 1 shows functional data at 5 min intervals during the 20 min stability period. 
Averaged over the 20 min period (±SEM), systolic pressure was 107±6 mmHg, end 
diastolic pressure (EDP) was 11±2 mmHg, left ventricular developed pressure (LVDP) 
was 96 ± 15 mmHg, heart rate (HR) was 455 ± 66 bpm and coronary flow was 2.3 ± 0.2 
ml/min.  
Figure 2(a) shows a representative 31P spectrum acquired in the mouse heart at 
baseline prior to intervention and is representative of normal cardiac energetics 
displaying resonances from adenosine triphosphate (ATP), phosphocreatine (PCr) and 
inorganic phosphate (Pi). Figure 2(b) shows a time-course of 23Na spectra acquired 
during perfusion with Tm(DOTP)5-. In the absence of shift reagent (time=0) the total Na 
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peak corresponds to the sum of contributions from intracellular [Na]i, extracellular 
/intravascular [Na]e, and from buffer surrounding the heart [Na]o. During infusion of 
shift reagent the 23Na signal from the extracellular/intravascular [Na]e pool is shifted 
first and at later times (5-10 mins) mixing of buffer surrounding the heart is achieved.  
Figure 3(a) shows the single quantum 23Na NMR spectrum acquired after 
infusion of shift reagent where an unshifted Na signal arising from the intracellular 
[Na]i pool, can readily be discerned and quantified. Fig. 3(b-d) shows representative 
23Na MQF spectra acquired in the presence of shift reagent where the positions of the 
relevant peaks are denoted by dashed lines. Fig. 3(b) shows the TQF signal arising 
principally from the intracellular [Na]i pool with a smaller contribution from the 
extracellular pool. The contribution to the total TQF signal arising from Nae acquired 
with shift reagent was Nae/(Nae+Nai) = 0.32 ± 0.06 (S.E. n= 6) corresponding to 32% of 
the total TQF signal. That is, in these experiments, 68% of the TQF signal reflects 
intracellular Na while 32% of the signal comes from extracellular sources. Fig. 3(c) 
shows the DQF spectrum acquired with shift reagent and a flip angle  = 54.7º showing 
exclusively extracellular Nae. Intracellular sodium was not observed employing the DQF 
sequence with a magic flip angle pulse. Fig. 3(d) shows the DQF spectrum acquired 
with shift reagent and a flip angle  = 90º showing both intracellular and extracellular 
Na and was not used further in this work due to a mixed contribution from both intra 
and extracellular Na pools. 
Figure 4 (a) shows the amplitude of the TQF and DQF signals acquired in an 
interleaved fashion during 20 mins stabilisation period and during 20 mins infusion of 
50M ouabain. Representative 23Na TQF and DQF spectra are shown in Fig. 4(b) during 
baseline stability, (c) after 20 mins infusion of ouabain (d) after 20 mins K+-free buffer 
and (e) after 20 mins K+-free/Ca2+-free buffer. A significant increase in the TQF signal 
was observed with respect to the baseline TQF signal with minimal changes in the DQF 
signal. The increase in [Na]i is consistent with the mode of action of ouabain and 
blocking of the Na/K ATPase or inhibition of Na efflux using modified buffers. 
Figure 5 shows a plot of the ratio of the TQF/DQF signals (RTQF/DQF) as a function 
of [Na]i measured with shift reagent, in control hearts at baseline [Na]i and in the four 
groups displaying elevated [Na]i after treatment with 50M ouabain (n=6); K
+-free 
(n=3), K+-free/Ca2+-free (n=3) and K+-free/Ca2+-free/Mg2+-free (n=3). The mean RTQF/DQF 
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was 3.0 ± 0.3 for control hearts, 4.4 ± 0.7 for 50M ouabain treatment, 5.2 ± 1.1 for K+-
free hearts, 7.7 ± 1.1 for K+-free/Ca2+-free and 6.3 ± 0.4 for K+-free/Ca2+-free/Mg2+-free 
with a measured [Na]i = 15.7 ± 1.6 mM; 25.5 ± 5.8 mM; 40.0 ± 5.7 mM, 57.9 ± 2.4 mM 
and 54.9 ± 6.5 mM, respectively. RTQF/DQF showed a good correlation with [Na]i. The 
intercept on the y-axis demonstrates a non-zero RTQF/DQF at [Na]i = 0mM confirming 
that there is a non-zero contribution from [Na]e to the TQF signal. From this line of fit, 
intracellular Na can be estimated from a measured RTQF/DQF according to the equation:  
[Na]i = (R
TQF/DQF  1.42)/0.10. This suggests that the extracellular contribution to the 
TQF signal is ~47%, therefore slightly greater than the 32% contribution estimated 
earlier in the presence of shift reagent, but lower than previously reported values for 
the rat heart of ~64% [13]. 
Figure 6 shows intracellular [Na]i measured in a cohort of wild type mice and in 
the PLM 3SA transgenic model. Fig. 6(a) shows [Na]i measured with the shift reagent 
technique for the two groups, with a measured [Na]i = 15.7 ± 1.6mM (n=6) in the WT 
and [Na]i = 20.5 ± 1.4mM (n=6) in the PLM 3SA (p=0.0497). Fig. 6(b) shows [Na]i 
measured from the TQF/DQF ratio using the calibration graph in Fig. 5. The TQF/DQF 
ratio was RTQF/DQF = 2.59 ± 0.09 in the WT group with an extrapolated value of [Na]i = 
11.6 ± 0.9mM (n=37) and RTQF/DQF = 3.12 ± 0.18 in the PLM 3SA group with an 
extrapolated [Na]i = 17.0 ± 1.8mM (n=21) (p=0.024). Employing the TQF/DQF ratio 
required a larger pooled number of hearts to show a significant difference between 
the groups. A modest but significant elevation of baseline [Na]i was measured in the 
PLM 3SA mouse compared to WT using both techniques.    
 
Discussion 
We have developed an MR-compatible Langendorff constant-pressure/constant flow 
perfusion system to non-invasively probe mouse myocardial [Na]i at physiological 
heart rates and temperatures. Multiple quantum filtering techniques (DQF and TQF) 
were used to monitor [Na]i during baseline physiological perfusion and during relative 
changes in [Na]i initiated by inhibition of the Na/K ATPase activity by 50M ouabain 
and modified KH buffers (K+-free, K+-free/Ca2+-free and K+-free/Ca2+-free/Mg2+-free 
KHB). Using the commonly used shift reagent, Tm(DOTP)5- to distinguish the relative 
contributions to the MQF signal from intra [Na]i and extracellular [Na]e, we were able 
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to quantify [Na]i and thereby compare these to the measurements obtained using the 
MQF experiments. In the presence of shift reagent we found that the proportion of the 
total TQF signal arising from the extracellular [Na]e pool was approximately 32%, 
indicating that the signal mainly represents [Na]i. We observed that the DQF signal was 
independent of elevations in [Na]i, consistent with this signal arising from the 
extracellular [Na]e pool. In both TQF and DQF multiple quantum filtered experiments 
the bulk isotropic Na signal is filtered out of the spectrum leaving only the Na pools 
subject to anisotropic interactions; the TQF arising due to biexponential relaxation and 
macromolecular Na binding in the intracellular matrix whilst the rank 2 DQF signal 
arises due to a residual quadrupolar coupling due to association with ordered 
structures such as tissue fibre orientation. The relative amplitudes of the TQF and DQF 
signals, with the former being greater than the latter, represent the different 
anisotropic environments found in these different compartments. We found a good 
correlation between the TQF/DQF ratio RTQF/DQF and [Na]i and propose, therefore, that 
this ratio can be used as a semi-quantitative measure of [Na]i in the mouse heart. 
Using the DQF signal as an internal extracellular reference on a heart-by-heart basis 
renders the TQF/DQF ratio independent of heart weight (data not shown), does not 
require an external [Na]ref standard for calibration and enables a direct measure of 
[Na]i without resorting to the use of shift reagents. 
Absolute quantification of [Na]i is challenging, particularly in the perfused 
mouse heart under physiological perfusion conditions. For the calculation of 
intracellular volume we assume a value of 2.5 ml/g dry weight of tissue which is 
adequate for the present control group of hearts [22]. This value is also in close 
agreement with that of 0.44ml/g wet weight estimated by Jelicks and Gupta [26]. 
However, exact measurement of intracellular volume would be required if these 
techniques are to be applied under conditions where this might change. It must also be 
noted that a large proportion of the intracellular pool may not be visible due to the 
quadrupolar nature of the intracellular 23Na+ bound to macromolecules. The NMR 
invisibility of a fraction of the intracellular Na has been reported by some [27] while 
others have reported that intracellular Na is 100% visible [26].   
While the extent of 23Na visibility may bias the absolute quantification of [Na]i 
using shift reagent [27], multiple quantum filtered 23Na will be useful to examine 
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relative changes in [Na]i applied to perfused mouse hearts. Both shift reagent and the 
TQF/DQF ratio were able to distinguish similar baseline differences in [Na]i in the two 
groups of hearts. The PLM 3SA genotype displayed a modest but significantly elevated 
[Na]i as measured both by shift reagent and the TQF/DQF ratio. However the poorer 
signal-to-noise ratio of the TQF and DQF NMR measurements compared to shift 
reagent, see Figure 3, resulted in a greater heart-to-heart variability, and therefore a 
larger pooled n number was required to reach significance between the two groups. 
There is also a slight discrepancy in the absolute magnitude of the measured [Na]i 
using the two techniques which may reflect the different measurement techniques as 
well as possible errors introduced in the derivation of the calibration curve. The 
difference might also reflect the different perfusion conditions, the groups measured 
with shift reagent being non-contracting due to the Ca chelation effect of the shift 
reagent whilst the TQF/DQF measurements are performed under more physiological 
conditions as reflected by the cardiac function in table 1. Whilst there was significant 
heart-to-heart variability in the TQF/DQF measurements requiring a large n number to 
distinguish baseline differences in [Na]i, the methods developed and validated in our 
study do not require the use of shift reagent, thus are performed under more 
physiological conditions, making our study readily applicable to the study of [Na]i 
regulation in a wealth of transgenic models and muscle types with chronically altered 
[Na]i. If absolute quantification of [Na]i is not required but relative changes with 
respect to baseline then the TQF measurement in the absence of DQF would also offer 
a viable and more reproducible alternative to the TQF/DQF ratio proposed here. 
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FIG. 1. NMR compatible Langendorff constant pressure perfusion system (a, b) and a 
schematic of the pneumatically driven three-way valve to allow switching between 
reservoirs with minimum dead-volume (c). 
  
Fig. 2. (a) Example 31P spectrum acquired during baseline stability period showing 
normal cardiac energetics. (b) Time-series of 23Na NMR spectra acquired in a perfused 
mouse heart during the infusion of Tm(DOTP) shift reagent. An initial shift of the 
intravascular extra cellular signal [Na]e is observed followed by the buffer surrounding 
the heart was achieved within a 5-10 mins timeframe.  
 
Fig. 3. (a) 23Na single quantum spectrum post infusion of shift reagent where the 
intracellular peak from [Na]i is clearly discerned. (b) TQF spectrum acquired from the 
same heart as in (a) in the presence of shift reagent showing predominantly 
intracellular [Na]i with a smaller contribution from extracellular [Na]e. (c) 
23Na DQF 
spectrum acquired with a flip angle  = 54.7º showing predominantly extracellular 
[Na]e. (d) 
23Na DQF spectrum acquired with a flip angle  = 90º showing both 
intracellular and extracellular Na. 
 
Fig. 4. (a) Peak areas shown for a time-series (±S.E. n=6) of 23Na TQF and DQF spectra 
acquired in an interleaved fashion in the perfused mouse heart during stability and 
during subsequent infusion of 50M ouabain, shaded area. Representative TQF and 
DQF spectra are shown; (b) during stability, (c) after 20 mins infusion of ouabain (d) 
after 20 mins K+-free buffer and (e) after 20 mins K+-free/Ca2+-free buffer.  
 
Fig. 5. Plot of the TQF/DQF ratio RTQF/DQF vs the measured concentration [Na]i in the 
perfused mouse heart at baseline (filled square, n=6) and following a 20 min 
intervention to elevate [Na]i; 50M ouabain (filled triangle, n=6); 0mM K
+ (open 
diamond, n=3), 0mM K+/0mM Ca2+ (filled circle, n=3) and 0mM K+/0mM Ca2+/0mM 
Mg2+ (open circle, n=3). Mean data are shown for each group ± S.E. 
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Fig. 6. Plot of measured [Na]i in the WT mouse and PLM 3SA transgenic mouse using 
(a) the shift reagent technique and (b) the derived values of [Na]i using the TQF/DQF 
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